A detailed history of Kerusso Capital Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Kerusso Capital Management LLC holds 47,111 shares of BMY stock, worth $2.65 Million. This represents 1.55% of its overall portfolio holdings.

Number of Shares
47,111
Previous 44,248 6.47%
Holding current value
$2.65 Million
Previous $1.84 Billion 32.65%
% of portfolio
1.55%
Previous 1.33%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$39.66 - $51.75 $113,546 - $148,160
2,863 Added 6.47%
47,111 $2.44 Billion
Q2 2024

Aug 06, 2024

BUY
$40.25 - $52.99 $1.78 Million - $2.34 Million
44,248 New
44,248 $1.84 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Kerusso Capital Management LLC Portfolio

Follow Kerusso Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kerusso Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kerusso Capital Management LLC with notifications on news.